insights_auto
Why is ARQT down 4.89%?
Dive Deeperchevron_right
ARQT:NASDAQ
Arcutis Biotherapeutics Inc
$23.92
arrow_downward
-4.89%(-1.23) 1D
$24.18
arrow_upward
+1.09% (+0.26)bedtimeAfter hours
Closed: Oct 6, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARQT...
Open
$25.37
High
$25.37
Low
$23.88
Mkt. cap
3.01B
Avg. vol.
2.91M
Volume
2.47M
P/E ratio
111.51
52-wk high
$31.77
52-wk low
$19.30
EPS
$0.21
Beta
1.57
Shares outstanding
125.69M
No. of employees
354
Open
$25.37
High
$25.37
Low
$23.88
Mkt. cap
3.01B
Avg. vol.
2.91M
Volume
2.47M
P/E ratio
111.51
52-wk high
$31.77
52-wk low
$19.30
EPS
$0.21
Beta
1.57
Shares outstanding
125.69M
No. of employees
354
News stories
From web sources and news partners
Seeking Alpha
·
7 hours ago
Arcutis Biotherapeutics: An Emerging GARP Stock (NASDAQ:ARQT)
Seeking Alpha
·
12 hours ago
Arcutis: Every Beat Gets Absorbed By A Shrinking Multiple (Rating Downgrade) (NASDAQ:ARQT)
Stock Titan
·
1 day ago
An iShares ETF has an interest above 5% in Arcutis (ARQT), where BlackRock reports a passive stake.
Stock Traders Daily
·
1 day ago
Trading Systems Reacting to (ARQT) Volatility
About Arcutis Biotherapeutics Inc
CEOFrank Watanabe
Employees354
Founded2016
HeadquartersWestlake Village, California, United States
SectorBiotechnology
Websitearcutis.com